抗淀粉样蛋白β免疫治疗阿尔茨海默病后的脑体积变化：淀粉样蛋白去除相关的假性萎缩（英文）
Progressive cerebral volume loss on MRI is a hallmark of Alzheimer's disease and has been widely used as an outcome measure in clinical trials, with the prediction that disease-modifying treatments would slow loss.
国外文献
2024年11月08日
